Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5528_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Preface
- •About the Editor
- •References
- •2. Eye, Posterior
- •Optical Coherence Tomography: Background and Principles
- •1. Eye, Anterior
- •Corneal Topography and Tomography
- •Ultrasound Biomicroscopy
- •Anterior Segment Optical Coherence Tomography
- •Confocal Microscopy
- •Specular Microscopy
- •Optical Coherence Tomography: Clinical Applications
- •Normal retinal anatomy
- •Retinal vascular disease: Diabetes, retinal vein, and artery occlusions
- •Choroidal disease: Age-related macular degeneration, myopic degeneration, and central serous chorioretinopathy (CSR)
- •Macular pucker and hole
- •Hereditary retinal dystrophies: Retinitis pigmentosa, Stargardt’s disease
- •Medication toxicity
- •Retinal detachment
- •Tumors (choroidal nevus, choroidal melanoma, and lymphoma)
- •References
- •3. Coronary Arteries
- •Introduction
- •Normal vessel wall, intimal thickening, and intimal xanthoma (fatty streak)
- •Pathological intimal thickening
- •Fibroatheroma
- •Ruptured plaques
- •Plaque erosion
- •Healed lesions
- •Imaging of Plaque Instability
- •Pathology of plaque instability
- •OCT imaging of plaque instability
- •Conclusion
- •References
- •4. Skin
- •Introduction
- •Optical Coherence Tomography (OCT)
- •Electrical Impedance Spectroscopy (EIS)
- •Future Directions
- •References
- •5. Upper Gastrointestinal Tract
- •Introduction
- •Esophagus
- •Stomach
- •Disclosures
- •References
- •6. Lower Gastrointestinal Tract
- •Introduction
- •Normal Microanatomy
- •Endoscopy
- •Confocal Laser Endomicroscopy
- •CLE of normal lower gastrointestinal tract
- •Limitations of CLE
- •Optical Coherence Tomography
- •Endocytoscopy
- •Enteropathy
- •Pouchitis
- •Celiac disease
- •Crohn’s disease
- •Ulcerative colitis
- •Pseudomembranous colitis
- •Intestinal spirochetosis
- •Microscopic colitis
- •Collagenous colitis
- •Lymphocytic colitis
- •Graft-versus-host disease (GVHD)
- •Neoplasia
- •Morphology
- •Molecular imaging
- •Computer-aided diagnosis (CAD)
- •References
- •7. Pancreaticobiliary System
- •Introduction
- •Pancreatic Cystic Lesions
- •EUS-nCLE image acquisition
- •Characteristics of in vivo microscopy of PCLs
- •Serous cystadenomas
- •Intraductal papillary mucinous neoplasm
- •Mucinous cystic neoplasms
- •Pseudocysts
- •Cystic neuroendocrine tumor
- •Squamous lined cysts (Lymphoepithelial cyst)
- •Differentiation of mucinous and non-mucinous PCLs
- •Future research in EUS-nCLE
- •Conclusion
- •Solid Pancreatic Lesions
- •Endomicroscopy characteristics of SPLs
- •Endomicroscopy of the Bile Duct
- •CLE image acquisition in the bile duct
- •Probe-based CLE patterns in biliary stenosis
- •Correlation of pCLE imaging of the bile duct with representative histology
- •Conclusion
- •References
- •8. Lungs
- •Introduction
- •Principle of optical imaging techniques
- •Role of ex vivo optical imaging techniques in lung cancer
- •FFOCT, MPM, and FCM can identify normal ex vivo lung tissue
- •FFOCT, MPM, and FCM can diagnose lung cancers in ex vivo tissue
- •In vivo application of optical imaging techniques in normal human lung and lung cancer
- •Conclusion
- •References
- •9. Breast
- •Introduction
- •Optical Mammography
- •Photoacoustic Imaging
- •Raman Spectroscopy
- •Future Directions
- •References
- •10. Central Nervous System
- •Introduction
- •Technique
- •Histopathology of Optical Images
- •Normal brain, dura, blood vessels, and blood
- •CNS Tumors
- •Artifacts
- •Limitations
- •Future Directions
- •Disclosures
- •Financial Support
- •Acknowledgments
- •Abbreviations
- •References
- •11. Head and Neck
- •Introduction
- •Applications
- •Diagnosis and evaluation
- •Surgical treatment
- •Current Limitations
- •Conclusion
- •References
- •12. Genitourinary System
- •Introduction
- •Bladder
- •Upper Urinary Tracts
- •Kidney
- •Prostate
- •Testis
- •Future Perspectives
- •References
- •13. Gynecologic Tract
- •Overview
- •IVM Applications in the Cervix
- •Optical spectroscopy and spectroscopic imaging
- •Spectroscopic imaging
- •Confocal microscopy
- •Optical coherence tomography
- •IVM detection of cervical neoplasia in resource-poor setting
- •Vulva
- •Histopathologic overview
- •IVM features of normal vulva
- •IVM features of vulvar pathology
- •Squamous dysplasia and carcinoma
- •Melanoma
- •Basal cell carcinoma
- •Extramammary Paget disease (EMPD)
- •Vagina
- •Histopathologic overview
- •IVM features of normal vagina
- •IVM features of vaginal pathology
- •Squamous dysplasia and carcinoma
- •Vaginal atrophy
- •Uterine Corpus
- •Ovary
- •Histopathologic overview
- •IVM features of normal ovary
- •IVM features of pathologic ovary
- •Fallopian Tube
- •Histopathologic overview
- •IVM features of normal fallopian tube
- •IVM features of pathologic fallopian tube
- •Peritoneum
- •Histopathologic overview
- •IVM features of normal peritoneum
- •IVM features of pathologic peritoneum
- •References
- •14. Hepatobiliary System
- •Introduction
- •Optical Coherence Tomography (OCT)
- •Conventional Confocal Microscopy and Confocal Endomicroscopy
- •Representative Human Confocal Laser Endomicroscopic Studies
- •Future Directions
- •Conclusion
- •References
- •15. Molecular Applications
- •References
- •Introduction
- •Intraoperative Evaluation of Surgical Margins
- •Applications in breast conservation surgery
- •Optical spectroscopy
- •Raman spectroscopy
- •Optical coherence tomography
- •Applications in Mohs micrographic surgery
- •Rapid lump examination
- •Confocal microscopy
- •Optical coherence tomography
- •Intraoperative Evaluation of Sentinel Lymph Nodes
- •Rapid Evaluation of Biopsy Adequacy
- •Conclusion
- •References
- •Index

20 N. Shah & A. Orlin
(a)
(b)
Figure 12. (a) Dense epiretinal membrane (arrow) with thickening and distortion of retinal contour.
(b) Follow-up, post surgery with improvement in retinal contour and resolution of thickening.
blindness. Retinitis pigmentosa is one such common disease that is associated with rod dysfunction giving symptoms of night blindness (nyctalopia)
early on and later severe peripheral vision loss. An electroretinogram is the
diagnostic modality of choice in such patients, especially early on during
the disease course when clinical exam may be unremarkable or only mildly
abnormal. In patients with this disease, OCT will show outer retinal atrophy and, in some patients, cystoid macular edema — a marker of retinal
disease and dysfunction (Figure 16(a) and (b), RP with outer retinal loss,
CME s/p treatment with topical CAIs). Another hereditary retinal degeneration, Stargardt’s disease affects the macula, responsible for central visual
dysfunction. Stargardt’s disease is characterized by hyperautofluorescent
flecks called lipofuscin which deposit along the RPE and secondary lead to
outer retinal disruption and atrophy (Figure 17, Stargardt’s pt). Stargardt’s
disease is the most common hereditary maculopathy seen in children.
4

Eye, Posterior 21
(a)
(b)
Figure 13. (a) Small full-thickness macular hole (arrow). (b) Spontaneous resolution with observation.
Medication toxicity
Several medications can cause changes to the retina. Of particular concern is toxic maculopathy from chloroquine or hydroxychloroquine. The
risk of retinal toxicity from these medications is low at approximately
1% after 5 years of use.
a bull’s eye maculopathy will be present. OCT will show characteristic
parafoveal loss of ellipsoid zone with a flying-saucer sign and relative
foveal sparing (Figure 18, hydroxychloroquine toxicity).
the American Academy of Ophthalmology requires SD OCT as part of
the routine testing protocol when screening for this disease.
retinal dystrophies can sometimes take on similar appearance, particularly
cone dystrophies or cone-rod dystrophies, and may be differentiated from
medication toxicity by history and electroretinogram. Other drugs, such as
niacin derivatives, taxane class chemotherapeutics,and the multiple sclerosis medication fingolimod, can give rise to cystoid macular edema (CME).
4
In later s tages of toxicity from these drugs,
2
For this reason,
9
Hereditary

22 N. Shah & A. Orlin
(a)
(b)
Figure 14. (a) Large full-thickness macular hole (arrow). (b) Closed following surgical intervention.
Figure 15. Lamellar hole with partial thickness retinal excavation (arrow).

Eye, Posterior 23
(a)
(b)
Figure 16. (a) Advanced retinitis pigmentosa with cystic edema (straight arrow) and outer retinal
atrophy (dashed arrow). (b) Resolution of cysts following topical therapy (arrow).
Figure 17. Stargardt’s disease with RPE deposits (straight arrow) and outer retinal atrophy (dashed
arrow).

24 N. Shah & A. Orlin
Figure 18. Plaquenil toxicity with ellipsoid layer loss (straight arrow); outer retina under fovea appears
relatively spared (dashed arrow).
(a)
(b)
Figure 19. (a) Medication-induced maculopathy with cystic intraretinal changes (arrow) from
fingolimod. (b) Resolution to normal anatomy following drug cessation.

Eye, Posterior 25
(a)
(b)
Figure 20. (a) Retinal detachment pre-operatively with subretinal fluid (straight arrow) and folds on
the undersurface of the retina (dashed arrow). The fovea is detached. (b) Following surgical repair,
the retina is attached to the wall of the eye.
The OCT appearance shows intraretinal cystic spaces in the inner nuclear
and outer plexiform layers. There may be the resolution of these changes
seen with cessation of the medication (Figure 19(a) and (b), CME from
Fingolimod, resolved following drug cessation).
Retinal detachment
A retinal detachment (RD) occurs when fluid extends into the subretinal
space and lifts the retina from its normal anatomical position. It can occur
secondary to a retinal break (termed rhegmatogenous retinal detachment),
from exudative processes, or due to overlying traction, such as in advanced

26 N. Shah & A. Orlin
(a)
(b)
Figure 21. (a) Fundus photography of well-circumscribed choroidal nevus (arrow). (b) OCT through
the lesion shows a flat, deep, hyperreflective change (arrow).
diabetic retinopathy. The most common type of RD is a rhegmatogenous
retinaldetachment. Some features ofOCT include the presence ofsubretinal
fluid, subretinal precipitates(if chronic fluid), and folds on the undersurface
of the retina (Figure 20(a) and (b), RRD pre and post repair). If the macula
is detached, visual prognosis is poorer than if it is attached. Chronic subretinal fluid sometimes may persist despite successful surgical repair and will
gradually resolve on its own with time. Outer retinal loss of photoreceptors

Eye, Posterior 27
Figure 22. Elevated choroidal lesion (straight arrow) with subretinal fluid (dashed arrow), suggestive
of choroidal melanoma vs choroidal nevus.
Figure 23. Diffuse lumpy bumpy infiltrate along retinal pigment epithelium (arrow) suggestive of
chorioretinal lymphoma.
may be seen in chronic macular-off retinal detachments and explains poor
vision following surgery despite anatomic success.
Tumors (choroidal nevus, choroidal melanoma, and lymphoma)
Choroidal nevi are benign acquired tumors seen commonly in clinical practice that appear as deep, pigmented, flat lesions. On OCT, they appear as
a well-circumscribed hyperreflective area deep in the RPE (Figure 21(a)
and (b), fundus photos of nevus with corresponding OCT).
2
EDI OCT

28 N. Shah & A. Orlin
helps to better visualize these lesions, given their depth. Most nevi are flat.
They may be associated with overlyingRPE changes or drusen, which suggest chronicity. Rarely, a nevus may transform into a choroidal melanoma.
Choroidal melanomas differ from nevi in that they are elevated and may be
associated with subretinalfluid and orange pigment (Figure 22, melanoma).
They also often cause symptoms such as floaters, photopsias, or visual distortion in the patient. Vitreoretinal lymphoma is another commonly seen
intraocular malignancy and in contrast to solid circumscribed tumors such
as melanoma, lymphoma has prominent vitreous cells and a lumpy bumpy
appearance to the outer retina, as lymphoma cells accumulate along Bruch’s
membrane and the RPE (Figure 23, lymphoma). A diagnostic vitrectomy
may be performed to confirm the diagnosis if MRI and lumbar puncture
are equivocal.
References
1. Huang, D., Swanson, E. A., Lin, C. P. et al. Optical coherence tomography, Sci-
ence. 254(5035): 1178–1181 (1991). doi:10.1126/science.1957169. PMID: 1957169;
PMCID: PMC4638169.
2. Duker, J. S., Waheed, N. K., and Goldman, D. Handbook of Retinal OCT. Elsevier
Saunders, Philadelphia, 2014.
3. Mohana, K. P., Das, D., and Muna, B. Optical coherence tomography: Newer tech-
niques, newer machines. Scientific Journal of Medical & Vision Research Foundations
XXXIII: 75–79 (2015).
4. McCannel, Colin A. Basic and Clinical Science Course, Section 12: Retina and Vitre-
ous. American Academy of Ophthalmology. United States of America, 2015.
5. Rosenfeld, et al. Ranibizumab for neovascular age-related macular degeneration. New
England Journal of Medicine, 355: 1419–1431 (2006).
6. Brown, D. M., et al. — ANCHOR Study Group. Ranibizumab versus verteporfin for
neovascular age-related macular degeneration. New England Journal of Medicine, 355:
1432–1444 (2006).
7. The CATT Research Group. Ranibizumab and bevacizumabfor neovascular age-related
macular degeneration. New England Journal of Medicine 364:1897–1908 (2011).
8. Heier, et al. — VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF
trap-eye) in wet age-related macular degeneration. Ophthalmology, 119(12): 2537–
2548 (2012).
9. Marmor, M. F. Recommendations on screening for chloroquine and hydroxychloro-
quine retinopathy (revision). Ophthalmology, 123: 1386–1394.

© 2024 World Scientific Publishing Company
https://doi.org/10.1142/9789813206984_0003
Coronary Arteries Chapter
3
Sho Torii∗,AlokeV.Finn∗, and Renu Virmani
∗
Introduction
Despite continued advances in medical therapies, coronary artery disease
(CAD) remains the major cause of morbidity and mortality throughout the
world. Cardiovascular disease (CVD) accounted for 17.3 million deaths
worldwide in 2012, and this number is expected to grow to >23.6 million by
1
2030.
early lesions developinginto more-advanced plaques which may or may not
result in clinical manifestations. Although the major coronary plaque types
underlying sudden cardiac death are well defined in the literature,
stable atherosclerotic lesions, such as fibroatheroma progress to unstable
“vulnerable” plaques (thin-cap fibroatheroma [TCFA] and rupture) is still
not well understood.
Progression of atherosclerosisis considered a dynamic process,with
2
how
∗
CVPath Institute Inc., Gaithersburg, MD, USA.
29
Соседние файлы в папке Библиотека им академика М.И. Перельмана
